Alberto Gimona
Fortuna: - $ al 31/08/2026
Fortuna: - $ al 31/08/2026
Alberto Gimona worked at Actelion Ltd. from 2011 to 2017 as Head-Clinical Science.
From 2019 to 2026, Dr. Gimona worked at Idorsia Ltd., serving as Head-Global Clinical Development & Executive VP from 2022 to 2026.
Dr. Gimona earned a doctorate from the University of Pisa.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IDORSIA LTD. -.--% | 31/12/2024 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| IDORSIA LTD | Corporate Officer/Principal | 01/05/2026 |
| ACTELION | Director Técnico/Científico/I+D | 01/01/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
University of Pisa
University of Pisa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idorsia Ltd.
Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.